Sinus thrombosis should be treated with anticoagulation

Archives of Neurology

Volumn 65, Issue 7, 2008, Pages 984-985

  Stam, J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN;

ABDUCENS NERVE PARALYSIS; ANTICOAGULATION; BRAIN HEMORRHAGE; BRAIN VEIN; CEREBRAL SINUS THROMBOSIS; COHORT ANALYSIS; GENETIC RISK; HEAD INJURY; HEADACHE; HUMAN; INTRACRANIAL HYPERTENSION; MORTALITY; OUTCOME ASSESSMENT; PAPILLEDEMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SHORT SURVEY;

ANTICOAGULANTS; HEPARIN; HUMANS; SINUS THROMBOSIS, INTRACRANIAL;

EID: 47549088123     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.65.7.984     Document Type: Short Survey

References (9)

1. Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35(3):664-670.
2. Fries G, Wallenfang T, Hennen J, et al. Occlusion of the pig superior sagittal sinus, bridging and cortical veins: multistep evolution of sinus-vein thrombosis. J Neurosurg. 1992;77(1):127-133.
3. Canhão P, Ferro JM, Lindgren AG, Bousser MG, Stam J, Barinagarrementeria F. Causes and predictors of death in cerebral venous thrombosis. Stroke. 2005;36(8):1720-1725.
4. Einhäupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet. 1991;338(8767):597-600.
5. de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke. 1999;30(3):484-488.
6. Stam J, De Bruijn SF, deVeber G. Anticoagulation for cerebral sinus thrombosis. Cochrane Database Syst Rev. 2002;(4):CD002005.
7. Sterne JA, Davey SG. Sifting the evidence-what's wrong with significance tests? BMJ. 2001;322(7280):226-231.
8. Shakespeare TP, Gebski VJ, Veness MJ, Simes J. Improving interpretation of clinical studies by use of confidence levels, clinical significance curves, and risk-benefit contours. Lancet. 2001;357(9265):1349-1353.
9. Krayenbühl HA. Cerebral venous and sinus thrombosis. Clin Neurosurg. 1966;14:1-24.